|
| |
Biovitrum ABBiovitrum is one of the largest biopharma companies in Europe. We combine research and development with process development and production of protein-based drugs and marketing of specialist pharmaceuticals
| Contact Details: |
| Berzelius väg 8 |
| Stockholm |
| |
| SE-112 76 |
| Sweden |
| Tel: | 46 8 697 20 00 |
| Fax: | 46 8 697 23 30 |
| Email: | info@biovitrum.com |
| WWW: | www.arexis.com/
|
| |
Recent Publications by Biovitrum AB: |  |
A versatile new synthetic route to 1N-hydroxyindazoles.
A new and versatile cyclization reaction affording rare... | 10th October, 2009
| Biovitrum AB, Discovery Research, 112 76 Stockholm, Sweden.
| Org Lett. 2009 Nov 5;11(21):5078-81.
DOI Direct Link |
N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.
Small molecule inhibitors of adipocyte fatty-acid binding protein (A-FABP)... | 21st August, 2009
| Department of Medicinal Chemistry, Biovitrum AB, Research, 112 76
| Bioorg Med Chem Lett. 2009 Mar 15;19(6):1745-8. Epub 2009 Jan 30.
DOI Direct Link |
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) has attracted... | 10th July, 2008
| Biovitrum
| J Med Chem. 2008 May 22;51(10):2933-43. Epub 2008 Apr 18.
DOI Direct Link |
Oxazolones as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
2,5,5-Trisubstituted oxazolones were identified as potent inhibitors of... | 6th December, 2007
| Biovitrum AB,
| Bioorg Med Chem Lett. 2007 Sep 1;17(17):4837-40. Epub 2007 Jun 20.
DOI Direct Link |
Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
A series of piperidine amide inhibitors of human 11beta-hydroxysteroid... | 31st August, 2007
| Biovitrum AB, SE-112
| Bioorg Med Chem Lett. 2007 Jun 15;17(12):3421-5. Epub 2007 Mar 30.
DOI Direct Link |
→View more Biovitrum AB research publications. |
Press Releases on Biovitrum AB:
|
 |
| BELLUS Health announces closing of Innodia acquisition |
17th July, 2008 |
BELLUS HEALTH INC. |
LAVAL, QC, July 17 /PRNewswire-FirstCall/ - BELLUS Health Inc. (NASDAQ:
BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced today the closing
of the acquisition of Innodia Inc. that it had
|
| ASINEX AND BIOVITRUM ANNOUNCE 3 YEAR DRUG DISCOVERY COLLABORATION |
1st January, 1970 |
Asinex |
ASINEX AND
BIOVITRUM ANNOUNCE 3 YEAR DRUG DISCOVERY COLLABORATION
Stockholm, Sweden and Moscow, Russia -
November, 23, 2004 - ASINEX Ltd, a worldwide leader in lead
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 15 individuals from Biovitrum AB using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 247 times since April 2007, the link to the organisation's website has been followed 24 times Search for more companies in Stockholm Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Biovitrum AB |
